- Article
- Published:
Medetomidine- and Medetomidine-Ketamine-induced Immobilization in Blue Foxes (Alopex lagopus) and its Reversal by Atipamezole
Medetomidin- och medetomidin-ketamin inducerad immobilisation hos blåräv (Alopex lagopus) samt dess upphävande med atipamezol.
Acta Veterinaria Scandinavica volume 31, pages 63–71 (1990)
Abstract
The sedative and immobilizing effects of the alpha2-adrenoceptor agonist medetomidine alone or combined with the dissociative anesthetic ketamine, were studied in blue foxes. Medetomidine at doses of 25 and 50 μg/kg induced moderate to deep sedation, but only with the highest medetomidine dose tested, 100 μg/kg, was the immobilization complete. Medetomidine 50 μg/kg combined with ketamine 2.5 mg/kg rapidly induced complete immobilization, characterized by good myorelaxation, and no clinically significant alterations in serially determined hematologic and serum chemistry parameters.
The alpha2-adrenoceptor antagonist atipamezole effectively reversed the medetomidine- or medetomidine-ketamine-induced immobilizations. A transient increase in heart rates was noted after each atipamezole injection.
Sammendrag
Medetomidin aliena eller i kombination med ketamin användes för immobilisering av blåräv. Med en dos på 20 och 50 μg/kg medetomidin, uppnåddes sedation. En fuliständig immobilisation och god mu-skelrelaxering uppnåddes med en dos på 100 μg/kg medetomidin och med 50 μg/kg medetomidin i kombination med 2.5 mg/kg ketamin. Atipamezol upphävde effektivt sedationen framkallad av medetomidin och medetomidin-ketamin.
References
Hsu WH, Zheng-Xing Lu, Hembrough FB: Effect of xylazine on heart rate and arterial blood pressure in conscious dogs, as influenced by atropine, 4-aminopyridine, doxapram, and yohimbine. J. Am. vet. med. Assoc. 1985, 186, 153–156.
Jalanka H: Clinical-pharmacological properties of a new sedative - medetomidine - and its antagonist, MPV-1248. In Proc. 1st Int. Conf. zool. and Avian Med. Hawaii 1987. Omnipress, Madison, Wisc. p. 530-534.
Jalanka H: Evaluation of medetomidine- and ketamine-induced immobilization in markhors (Capra falconeri megaceros) and its reversal by ati-pamezole. J. Zoo. Anim. Med. 1988, 19, (3): 95–105.
Jalanka H: Medetomidine- and ketamine-induced immobilization in snow leopards (Panthera uncia): doses, evaluation, and reversal by atipamezole. J. Zoo. and Wildl. Med. 1989, 20, 154–162.
JalankaH, SkutnabbK, Damstén Y: Preliminary results on the use of medetomidine-ketamine combinations in the dog. Acta vet. scand. 1989, Supplement 85, p. 125–128.
Järvensivu P, Kettunen R, Leskinen M, Pesola M, Rämö P, Timisjärvi J, Hirvonen L: The immediate circulatory effects of intravenously administered MPV-785 (medetomidine) in the dog. J. cardiovasc. Pharmacol. 1990, in press.
Kreeger TJ, Faggella AM, Seal US, Mech LD, Callahan M, Hall B: Cardiovascular and behavioral responses of gray wolves to ketamine-xylazine immobilization and antagonism by yohimbine. J. Wildl. Dis. 1987, 23, 463–470.
Kreeger TJ, Seal US: Failure of yohimbine hydrochloride to antagonize ketamine hydrochloride immobilization in gray wolves. J. Wildl. Dis. 1986, 22, 600–603.
McWade DH: An evaluation of ketamine and xylazine in combination as agents for the remote chemical immobilization of feral and stray dogs. In: Nielsen L, Haigh JC, Fowler ME (eds.): Chemical Immobilization of North American Wildlife. Wisconsin Humane Society, Inc. 1982. p. 175–187.
Nilsfors L, Kvart C: Preliminary report on the cardiorespiratory effects of the antagonist to deto-midine, MPV-1248. Acta vet. scand. 1986, Supplement 82, p. 121–129.
Philo LM: Evaluation of xylazine for chemical restraint of captive arctic wolves. J. Am. vet. med. Assoc. 1978, 173, 1163–1166.
Röken BO: Medetomidine in zoo animal anaesthesia. In Proc. 1st Int. Conf. Zool. and Avian Med. Hawaii 1987. Omnipress, Madison. Wisc. p. 535–538.
Savola J-M, Ruskoaho H, Puurunen J, Salonen JS, Kärki NT: Evidence for medetomidine as a selective and potent agonist at alpha2-adrenoceptors. J. auton. Pharmacol. 1986, 5, 275–284.
Vainio O, Palmu L: Cardiovascular and respiratory effects of medetomidine in dogs and influence of anticholinergics. Acta vet. scand. 1989, 30, 401–407.
Vainio O, Palmu L, Virtanen R, Wecksell J: Medetomidine, a new sedative and analgesic drug for dogs and cats. J. Assoc. vet. Anaesth. (U.K.) 1987, 14, 53–55.
Virtanen R, MacDonald E: Reversal of the sedative/analgesic and other effects of detomidine and medetomidine by MPV-1248, a novel alpha2-an-tagonist. Pharmacol. & Toxicol. 1987, 60, (Supplement III), 53.
Virtanen R, Savola J-M, Saano V: Highly selective and specific antagonism of central and peripheral alpha2-adrenoceptors by atipamezole. Arch, int. Pharmacodyn. 1989, 297, 190–204.
Wallach JD, Boever WJ: Diseases of Exotic Animals. W. B. Saunders Co., Philadelphia 1983, p. 405–463.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jalanka, H.H. Medetomidine- and Medetomidine-Ketamine-induced Immobilization in Blue Foxes (Alopex lagopus) and its Reversal by Atipamezole. Acta Vet Scand 31, 63–71 (1990). https://doi.org/10.1186/BF03547578
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03547578